#PFE - 1H - MACD divergece already descounted? Notable divergence on our 1H MACD. The key question here is that if has been already discounted on the last bullish run from 31 USD to 36 USD? Today we have reach an importan resistance on 37 USD level. If there is not any news about COVID vaccine among these days, we will have a healthy correction of the price...
Why: Weekly Bearshirsh pattern break. Risk:reward:-1:2 StopLoss:3970 Target:4180 Target2:4350
Right now one of the stocks that have my attention, (partly because of Kevin O'Leary) and the rest of its history is Mind Medicine (MindMed Inc.) They are one of the first companies finding a way to neutralize LSD while working on a DMT based therapy drug. Also, the market cap and entry is low. This is one of those stocks where you need to dig deep into the pitch...
Biogen today reported a huge earning beat, but disappointing guidance for the rest of the year. When you crunch the numbers, the midpoint of Biogen's guidance range for 2H 2020 came in slightly below Street consensus for both earnings and revenues. Biogen has a reasonable, but not great valuation, with forward PEG of 3.78 and forward PSG of 1.27. It's currently...
Abbvie's volume has slackened somewhat after its recent triangle breakout, and it has broken its steep upward trendline. We may see a small correction late this month as Abbvie pulls back toward triangle top. However, if healthcare and pharmaceutical sector earnings continue to deliver this month (as they have so far), then Abbvie should get some buying volume...
FA: Earings release- the last earnings where the estimate was higher than 0.05 per share it led to the stock rallying by 40%- unless, the earings surprise is a negative one; we can expect a rally from Vanda Pharmaceuticals. TA: Currently been trading in a limited channel- lack of momentum could lead to a dump if earnings estimate is negative or perhaps mean no...
$ABT is forming cup needs to hold above $100 for a confirmation. watch for a heavy volume as well 12 months Consensus Price Target: $103.67 if you find my charts useful, please leave me "like" or "comment". Please don't trade according to the ideas, rely on your own knowledge. Thx
Formations drawn Rising Wedge Scythe I expect a breakdown of this weird wedge that has formed between a major trendline and a line of strong bounce areas
EQ reached top mover status as a gainer one day and a loser the following day. Thursday, EQ was up +1.49% pre-market. I predict stock moves at a steady pace toward $24 price target. EQ is a mall biotech company researching Alzheimer's medicine. Healthcare is our third-largest sector ($6.2 T). Financials ($7.53 T) ranks second and information technology...
Yet another potentially profitable play regarding the Covid-19 pandemic is $MRNA, A pharmaceutical company that is currently entering its 3rd phase of a corona Vaccine. While this play depends largely on its vaccine success over the rest of the month this could be an extremely lucrative play. It has been in a consolidation zone for the past few weeks, a Good buy...
One can trade in this script with immediate target of 570 followed by 610 and higher before stock split, keep stop loss at 500. Good luck and have a great profitable day. For long term investors keep it in your portfolio and hold for multi fold returns. for more you can visit my site 5nancial.blogspot.com
Vaxart (VXRT, $8) was one of top quarterly gainers, jumping +376.19% to $8 per share. Tickeron A.I.dvisor analyzed 174 stocks in the Pharmaceuticals: Major Industry over the last three months, and discovered that 155 of them (89.09%) charted an Uptrend while 19 of them (10.91%) trended down. Tickeron A.I.dvisor found 135 similar cases when VXRT's price went up 15%...
I think this is probably where I will place bids on NOVN.. Still looking weak AF right now.
GLENMARK 01 JULY 2020 SHORT-SELL 2/3 LOT OF GLENMARK @ 430 Dear traders kindly follow our signals for maximum profits, our signals are based on analytics, algorithms, mathematical derivatives. Always be a responsible trader, kindly trade only when you have maximum opportunity in the market with minimum risk and with keynotes like data,analysis and proper...
PFE continues to underperform on the long-term and under the recent fundamentals the pressure on it is growing. The Bearish Megaphone on 1D (RSI = 33.977, MACD = -1.120, ADX = 56.370) has printed a bearish continuation sequence that extends at least towards the 27.90 Support. ** If you like our free content follow our profile to get more daily ideas. **...
Nektar Therapeutics (NKTR, $22.82) was one of top quarterly gainers, jumping +40.26% to $22.82 per share. My A.I.dvisor analyzed 169 stocks in the Pharmaceuticals: Major Industry over the last three months, and discovered that 156 of them (92.52%) charted an Uptrend while 13 of them (7.48%) trended down.My A.I.dvisor found 426 similar cases when NKTR's price went...
A buy signal is generated. When the green line goes above 70 while the red line stays below 30, this is an indicator that the stock could be poised for a strong Uptrend. For traders, this could mean going long the stock or exploring call options in the next month. I backtested this indicator and found 162 similar cases, 149 of which were successful. Based on this...